KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Cash from Investing Activities (2016 - 2025)

Idexx Laboratories (IDXX) has 17 years of Cash from Investing Activities data on record, last reported at -$28.1 million in Q4 2025.

  • For Q4 2025, Cash from Investing Activities rose 29.4% year-over-year to -$28.1 million; the TTM value through Dec 2025 reached -$136.2 million, up 34.2%, while the annual FY2025 figure was -$136.2 million, 34.2% up from the prior year.
  • Cash from Investing Activities reached -$28.1 million in Q4 2025 per IDXX's latest filing, up from -$44.9 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$24.6 million in Q1 2021 and bottomed at -$174.7 million in Q2 2021.
  • Average Cash from Investing Activities over 5 years is -$47.8 million, with a median of -$39.7 million recorded in 2023.
  • Peak YoY movement for Cash from Investing Activities: tumbled 611.28% in 2021, then soared 72.31% in 2025.
  • A 5-year view of Cash from Investing Activities shows it stood at -$44.0 million in 2021, then dropped by 11.78% to -$49.2 million in 2022, then surged by 38.18% to -$30.4 million in 2023, then plummeted by 30.91% to -$39.8 million in 2024, then rose by 29.4% to -$28.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Investing Activities were -$28.1 million in Q4 2025, -$44.9 million in Q3 2025, and -$33.6 million in Q2 2025.